Literature DB >> 17362979

Automated high-throughput purification of antibody fragments to facilitate evaluation in functional and kinetic based assays.

Bin Su1, Renee Hrin, Barrett R Harvey, Ying-Jie Wang, Robin E Ernst, Richard A Hampton, Michael D Miller, William R Strohl, Zhiqiang An, Donna L Montgomery.   

Abstract

Screening antibodies from phage displayed in vitro libraries and from affinity maturation of lead antibodies requires testing of antibody fragments (scFvs and Fabs) for function and binding affinities. Crude scFv or Fab periplasmic preparations from Escherichia coli are often not pure and/or concentrated enough for use in functional and affinity assays. We have developed an automated high-throughput approach for small and large-scale expression and purification of His-tagged scFvs and Fabs using the Qiagen BioRobot 3000 LS with optimized application software. This automated procedure enabled us to rapidly evaluate antibody fragments in functional and surface plasmon resonance (SPR) assays. We have used these procedures to make thousands of purified scFv/Fabs for several antibody maturation campaigns and significantly decreased the time needed to select the best candidates. The assay results from these purified samples were used to prioritize candidates before converting them to IgG. This protocol can process up to 300 small-scale and up to 72 large-scale scFvs or Fabs per week per full-time employee (FTE).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17362979     DOI: 10.1016/j.jim.2007.02.006

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41.

Authors:  Donna L Montgomery; Ying-Jie Wang; Renee Hrin; Micah Luftig; Bin Su; Michael D Miller; Fubao Wang; Peter Haytko; Lingyi Huang; Salvatore Vitelli; Jon Condra; Xiaomei Liu; Richard Hampton; Andrea Carfi; Antonello Pessi; Elisabetta Bianchi; Joseph Joyce; Chris Lloyd; Romas Geleziunas; David Bramhill; Vicki M King; Adam C Finnefrock; William Strohl; Zhiqiang An
Journal:  MAbs       Date:  2009-09-08       Impact factor: 5.857

2.  Aglycosylated antibodies and antibody fragments produced in a scalable in vitro transcription-translation system.

Authors:  Gang Yin; Eudean D Garces; Junhao Yang; Juan Zhang; Cuong Tran; Alexander R Steiner; Christine Roos; Sunil Bajad; Susan Hudak; Kalyani Penta; James Zawada; Sonia Pollitt; Christopher J Murray
Journal:  MAbs       Date:  2012-03-01       Impact factor: 5.857

3.  Application of the Protein Maker as a platform purification system for therapeutic antibody research and development.

Authors:  Geneviève Hélie; Marie Parat; Frédéric Massé; Cory J Gerdts; Thomas P Loisel; Allan Matte
Journal:  Comput Struct Biotechnol J       Date:  2016-06-16       Impact factor: 7.271

4.  Hapten mediated display and pairing of recombinant antibodies accelerates assay assembly for biothreat countermeasures.

Authors:  Laura J Sherwood; Andrew Hayhurst
Journal:  Sci Rep       Date:  2012-11-12       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.